miltefosine has been researched along with Body Weight in 5 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To estimate drug costs of treating visceral leishmaniasis (VL) based on data on the VL population structure from the high-burden, antimony-resistant area of Northern Bihar, India." | 1.35 | Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. ( Olliaro, P; Sundar, S, 2009) |
| " However, the concept of clinical trials requires new approaches to dose finding and response evaluation, because the dose-response relationship of this compound is distinctly different from that of classical cytostatic agents." | 1.30 | D-21266, a new heterocyclic alkylphospholipid with antitumour activity. ( Engel, J; Hilgard, P; Klenner, T; Kutscher, B; Nössner, G; Stekar, J, 1997) |
| " Single administration of equimolar HePC doses results in differing pharmacokinetic values for free HePC (p." | 1.29 | Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine. ( Berger, MR; Drevs, J; Eibl, H; Kaufmann-Kolle, P; Kötting, J; Marschner, N; Unger, C, 1994) |
| "The histopathological change from tubular adenocarcinoma to malignant adenoacanthoma might be caused by an overgrowth of the primary epithelial tumor cells or by a real transformation in the morphological characteristics of the tumor, which may occur during repeated transplantation." | 1.28 | Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats. ( Amelung, F; Berger, MR; Heyl, P; Reinhardt, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olliaro, P | 1 |
| Sundar, S | 1 |
| Bianciardi, P | 1 |
| Brovida, C | 1 |
| Valente, M | 1 |
| Aresu, L | 1 |
| Cavicchioli, L | 1 |
| Vischer, C | 1 |
| Giroud, L | 1 |
| Castagnaro, M | 1 |
| Kaufmann-Kolle, P | 1 |
| Drevs, J | 1 |
| Berger, MR | 2 |
| Kötting, J | 1 |
| Marschner, N | 1 |
| Unger, C | 1 |
| Eibl, H | 1 |
| Hilgard, P | 1 |
| Klenner, T | 1 |
| Stekar, J | 1 |
| Nössner, G | 1 |
| Kutscher, B | 1 |
| Engel, J | 1 |
| Reinhardt, M | 1 |
| Heyl, P | 1 |
| Amelung, F | 1 |
5 other studies available for miltefosine and Body Weight
| Article | Year |
|---|---|
Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.
Topics: Adolescent; Adult; Age Distribution; Aged; Amphotericin B; Anthropometry; Antiprotozoal Agents; Body | 2009 |
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.
Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytoc | 2009 |
Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Chromatography, High Pressure Liq | 1994 |
D-21266, a new heterocyclic alkylphospholipid with antitumour activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Dose-Response Relatio | 1997 |
Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Body Weight; Female; Keratins; Ma | 1992 |